Stock Earnings

Question 1

Quels sont les états financiers clés de Assembly Biosciences Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Assembly Biosciences Inc a un total d'actifs de $119, un bénéfice net loss de $-40

Question 2

Quels sont les ratios financiers clés pour ASMB ?

Accepted Answer

Le ratio de liquidité de Assembly Biosciences Inc est 1.4, la marge nette est -142.85, les ventes par action sont de $4.66.

Question 3

Comment les revenus de Assembly Biosciences Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Assembly Biosciences Inc largest revenue segment is Innovative Therapeutics Targeting Serious Viral Diseases, at a revenue of 28,520,000 in the most earnings release.For geography, United States is the primary market for Assembly Biosciences Inc, at a revenue of 28,520,000.

Question 4

Assembly Biosciences Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Assembly Biosciences Inc a un bénéfice net loss de $-40

Question 5

Assembly Biosciences Inc a-t-elle des passifs ?

Accepted Answer

yes, Assembly Biosciences Inc a un passif de 85

Question 6

Combien d'actions en circulation Assembly Biosciences Inc a-t-elle ?

Accepted Answer

Assembly Biosciences Inc a un total d'actions en circulation de 7.45

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	33	28	7	0	6	79
Revenue Growth (YoY)	56.99%	300%	--	-100%	-92%	426.99%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	17	18	22	23	28	36
Research & Development	58	55	48	69	70	101
Operating Expenses	76	73	71	93	98	138
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-39	-39	-61	-93	-132	-62
Income Tax Expense	0	0	0	0	-2	--
Net Income	-38	-40	-61	-93	-129	-62
Net Income Growth	-16%	-34%	-34%	-28%	108%	-36%
Shares Outstanding (Diluted)	7.65	6	4.57	4.03	3.6	2.95
Shares Change (YoY)	36%	31%	13%	12%	22%	35%
EPS (Diluted)	-5.08	-6.69	-13.38	-23.08	-36.01	-21.05
EPS Growth	-37%	-50%	-42%	-36%	71%	-53%
Free Cash Flow	-55	-51	22	-84	-96	-65
Free Cash Flow Per Share	-7.18	-8.49	4.8	-20.82	-26.61	-22.01
Gross Margin	--	--	--	--	--	--
Operating Margin	-130.3%	-160.71%	-914.28%	0%	-1,533.33%	-74.68%
Profit Margin	-115.15%	-142.85%	-871.42%	0%	-2,150%	-78.48%
Free Cash Flow Margin	-166.66%	-182.14%	314.28%	0%	-1,600%	-82.27%
EBITDA	-43	-45	-64	-93	-92	-59
EBITDA Margin	-130.3%	-160.71%	-914.28%	0%	-1,533.33%	-74.68%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-43	-45	-64	-93	-92	-59
EBIT Margin	-130.3%	-160.71%	-914.28%	0%	-1,533.33%	-74.68%
Effective Tax Rate	0%	0%	0%	0%	1.51%	--

Assembly Biosciences Inc (ASMB) Price

ASMB Stock Price Chart

ASMB Income

Follow-Up Questions